Royalty Pharma PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great, everybody. Good morning again. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biopharma analysts here at Morgan Stanley, and pleased to have Royalty Pharma with us.
Quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So, pleased to have the team with us. I'm going to turn it over to Pablo, who will make some opening comments, and then we'll jump into Q&A.
Thank you, Matt, and thank you for the invitation to join you this morning. And I'd like just to start by saying that in this session, we're going to be making forward-looking statements, and I'd like to refer you to our 10-K. But with that, let me start, and I thought what I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |